Actively Recruiting
Evaluating Morning Bright Light Therapy Using Re-Timer Device for Postpartum Depression An Open-Label Study on Feasibility and Acceptability of Circadian-Focused Treatment
Led by University of Michigan · Updated on 2026-08-14
30
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of a wearable morning bright light therapy device called Re-Timer for women experiencing postpartum depression who are within six months after giving birth. The study aims to understand how feasible and acceptable this light therapy is, as well as the context in which it could be implemented for this condition. Participants will use the Re-Timer device daily for about 60 minutes each morning during a 5-week treatment period. The study includes approximately 30 women who have a postpartum depression score above 10 on the Edinburgh Postnatal Depression Scale. This open-label trial focuses on the effects and user experience of the light therapy without a comparison group. During the study, participants will be monitored for how well they adhere to the treatment and their retention in the study over the 5 weeks. Researchers will assess client satisfaction and treatment satisfaction through self-reported questionnaires. The study will track these outcomes around 5 weeks after starting the light therapy to evaluate its acceptability and practical use for postpartum depression.
CONDITIONS
Brief Title
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Research Team
K
Kelley DuBuc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here